A patient with a neuroendocrine tumor secreting large amounts of GLP-1 and GLP-2 exhibited delayed transit through the gastrointestinal tract, including the colon (153), whereas the use of GLP-1RAs has recently been reported to be associated with lower quality bowel preparation for colonoscopy (154). Here, GCG is linked to neuroendocrine neoplasm.